118 related articles for article (PubMed ID: 11511251)
1. Synthesis of novel retinoid X receptor-selective retinoids.
Faul MM; Ratz AM; Sullivan KA; Trankle WG; Winneroski LL
J Org Chem; 2001 Aug; 66(17):5772-82. PubMed ID: 11511251
[TBL] [Abstract][Full Text] [Related]
2. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.
Howell SR; Shirley MA; Ulm EH
Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386
[TBL] [Abstract][Full Text] [Related]
3. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
[TBL] [Abstract][Full Text] [Related]
4. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells.
Haxsen V; Adam-Stitah S; Ritz E; Wagner J
Circ Res; 2001 Mar; 88(6):637-44. PubMed ID: 11282899
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.
Boehm MF; Zhang L; Badea BA; White SK; Mais DE; Berger E; Suto CM; Goldman ME; Heyman RA
J Med Chem; 1994 Sep; 37(18):2930-41. PubMed ID: 8071941
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of stilbene retinoid analogs substituted with heteroaromatic carboxylic acids.
Beard RL; Chandraratna RA; Colon DF; Gillett SJ; Henry E; Marler DK; Song T; Denys L; Garst ME; Arefieg T
J Med Chem; 1995 Jul; 38(15):2820-9. PubMed ID: 7636843
[TBL] [Abstract][Full Text] [Related]
7. The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo.
Cesario RM; Klausing K; Razzaghi H; Crombie D; Rungta D; Heyman RA; Lala DS
Mol Endocrinol; 2001 Aug; 15(8):1360-9. PubMed ID: 11463859
[TBL] [Abstract][Full Text] [Related]
8. Selective RXR modulators for the treatment of type II diabetes.
Faul MM; Grese TA
Curr Opin Drug Discov Devel; 2002 Nov; 5(6):974-85. PubMed ID: 12478728
[TBL] [Abstract][Full Text] [Related]
9. Solution-phase synthesis of diaryl selenides using polymer-supported borohydride.
Millois C; Diaz P
Org Lett; 2000 Jun; 2(12):1705-8. PubMed ID: 10880206
[TBL] [Abstract][Full Text] [Related]
10. Receptor specificity of retinoid-induced epidermal hyperplasia: effect of RXR-selective agonists and correlation with topical irritation.
Thacher SM; Standeven AM; Athanikar J; Kopper S; Castilleja O; Escobar M; Beard RL; Chandraratna RA
J Pharmacol Exp Ther; 1997 Aug; 282(2):528-34. PubMed ID: 9262312
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.
Schaier M; Liebler S; Schade K; Shimizu F; Kawachi H; Grone HJ; Chandraratna R; Ritz E; Wagner J
J Mol Med (Berl); 2004 Feb; 82(2):116-25. PubMed ID: 14712350
[TBL] [Abstract][Full Text] [Related]
12. Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP-II and RARbeta expression.
Hewson QC; Lovat PE; Pearson AD; Redfern CP
J Cell Biochem; 2002; 87(3):284-91. PubMed ID: 12397610
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.
Boehm MF; Zhang L; Zhi L; McClurg MR; Berger E; Wagoner M; Mais DE; Suto CM; Davies JA; Heyman RA
J Med Chem; 1995 Aug; 38(16):3146-55. PubMed ID: 7636877
[TBL] [Abstract][Full Text] [Related]
14. Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
Makishima M; Shudo K; Honma Y
Biochem Pharmacol; 1999 Mar; 57(5):521-9. PubMed ID: 9952315
[TBL] [Abstract][Full Text] [Related]
15. Retinoid X receptor agonist elevation of serum triglycerides in rats by potentiation of retinoic acid receptor agonist induction or by action as single agents.
Standeven AM; Thacher SM; Yuan YD; Escobar M; Vuligonda V; Beard RL; Chandraratna RA
Biochem Pharmacol; 2001 Dec; 62(11):1501-9. PubMed ID: 11728386
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.
Canan Koch SS; Dardashti LJ; Cesario RM; Croston GE; Boehm MF; Heyman RA; Nadzan AM
J Med Chem; 1999 Feb; 42(4):742-50. PubMed ID: 10052980
[TBL] [Abstract][Full Text] [Related]
17. An efficient, stereospecific synthesis of the dimer-selective retinoid X receptor modulator (2E,4E,6Z)-7-[5,6,7,8- tetrahydro-5,5, 8,8-tetramethyl-2-(n-propyloxy)naphthalen-3-yl]-3-methyl octa-2,4, 6-trienoic acid.
Hamann LG
J Org Chem; 2000 May; 65(10):3233-5. PubMed ID: 10814223
[No Abstract] [Full Text] [Related]
18. [Studies on the structure-activity relationship of retinoids--Hansch analysis and 3D-OSAR studies on specific ligands of retinoid x receptor].
Huang N; Chu F; Guo Z
Yao Xue Xue Bao; 1998 Jun; 33(6):442-8. PubMed ID: 12016914
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid receptor- and retinoid X receptor-selective retinoids activate signaling pathways that converge on AP-1 and inhibit squamous differentiation in human bronchial epithelial cells.
Lee HY; Dawson MI; Walsh GL; Nesbitt JC; Eckert RL; Fuchs E; Hong WK; Lotan R; Kurie JM
Cell Growth Differ; 1996 Aug; 7(8):997-1004. PubMed ID: 8853895
[TBL] [Abstract][Full Text] [Related]
20. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
